Subgroup Complications | Control | Number of studies | Results of heterogeneity test | Meta analysis results | ||
---|---|---|---|---|---|---|
P value | I2 | MD (95% CI) | P value | |||
(A) injection pain | NS group | 4 | 0.12 | 48% | 0.20(0.08,0.49) | 0.0004 |
(B) body movement | NS group | 4 | 0.15 | 44% | 0.76(0.65,0.90) | 0.001 |
opioids group | 2 | 0.64 | 0% | -0.11(0.21, -0.00) | 0.05 | |
(C) hypotension | NS group | 6 | 0.006 | 69% | 0.31(0.22,0.43) | 0.003 |
opioids group | 3 | 0.47 | 0% | -0.14(-0.21, -0.06) | 0.0002 | |
(D) respiratory depression | NS group | 6 | 0.29 | 19% | 0.33(0.19,0.58) | 0.0001 |
opioids group | 4 | < 0.001 | 86% | -0.15(-0.29, -0.00) | 0.05 | |
(E)nausea or vomiting | NS group | 5 | 0.40 | 1% | 0.78(0.30,2.04) | 0.61 |
opioids group | 4 | < 0.001 | 90% | -0.18(-0.41,0.04) | 0.11 | |
(F)Hypoxemia | NS group | 3 | 1.05 | 47% | 1.05(0.68,1.62) | 0.84 |
opioids group | 2 | 0.33 | 0% | -0.00(-0.06,0.06) | 0.94 | |
(G) hypertension | opioids group | 3 | 0.07 | 62% | -0.04(-0.13,0.05) | 0.42 |
(H)bradycardia | NS group | 3 | 0.54 | 0% | 0.71(0.14,3.66) | 0.68 |
opioids group | 3 | 0.06 | 64% | -0.01(-0.10,0.08) | 0.85 | |
(I)tachycardia | opioids group | 2 | 0.50 | 0% | 0.03(-0.04,0.10) | 0.40 |
(J)delirium | NS group | 2 | 0.11 | 61% | 3.29(0.61,17.83) | 0.17 |
(K)dizziness | NS group | 6 | 0.99 | 0% | 1.38(0.94,2.02) | 0.10 |
(L) Visual disturbance | NS group | 3 | 0.56 | 0% | 5.84(1.88,18.20) | 0.002 |